Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Solid Tumors 6Advanced Solid Tumor 4Solid Tumor, Adult 2Advanced Solid Tumors 2Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumor 1Patients With Advanced or Metastatic Solid Tumors 1Neoplasms 1Metastatic Solid Tumors 1Mesothelioma, Malignant 1Malignant Solid Tumour 1Locally Advanced or Metastatic Solid Tumors 1KRAS Mutant Solid Tumors 1

Interventions

Injections 27Carboplatin 18Docetaxel 14pembrolizumab 13Paclitaxel 12Bevacizumab 10durvalumab 8Nivolumab 8Cisplatin 8Fluorouracil 7Pemetrexed 6Oxaliplatin 6Leucovorin 6trifluridine tipiracil drug combination 5toripalimab 5tislelizumab 5linifanib 5Capecitabine 5zimberelimab 4talazoparib 4olaparib 4fludarabine 4Panobinostat 4Itraconazole 4Irinotecan 4Gemcitabine 4Everolimus 4tremelimumab 3sotorasib 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Solid Tumors × Cetuximab × Other solid neoplasm × Clear all
NCT05067283 2026-05-26

KANDLELIT-001

Merck Sharp & Dohme LLC

Phase 1 Recruiting
830 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06715124 2026-03-02

QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations

Quanta Therapeutics

Phase 1 Active not recruiting
237 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡